跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABLAVAR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ABLAVAR
Authorized
STANDARD
ABLAVAR
Lantheus Mi Canada, Inc.
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
a5393479cfc96aec
Company
Lantheus Mi Canada, Inc.
Type
Standard
Approval Details
Approval Id
a5393479cfc96aec
Drug Approval Canada Name
ABLAVAR
Product Name
ABLAVAR
Status
Cancelled Post Market
Status Date
2016-03-07
Original Market Date
2010-10-12
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
ETHICAL
Ahfs
36:89.00* See footnote 6
Atc Original
V08CA11 GADOFOSVESET
Aig Number
0151671001
Company Name
Lantheus Mi Canada, Inc.
Company Address
1111 Dr. Frederik-Philips Blvd., Suite 600 Montreal Quebec Canada H4M 2X6
Company Detail Path
/organization/lantheus-mi-canada-inc
Company Information
Pharmaceutical Company Name
Lantheus Mi Canada, Inc.
Country Name
Canada
Province Name
Ontario
City Name
hamilton,ontario,country_ca
Address
67 Frid St
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
a5393479cfc96aec
Type
Standard
Back to Health Canada Approvals